Top Header Menu

You are here: Home > Therapy > Neurofeedback

Archive | Neurofeedback

ISNR Kicks Off Promotional Campaign To Increase Public Awarenes Of Neurofeedback

By Christopher Fisher, PhD on July 11, 2009 in Neurofeedback

a href=”http://www.isnr.org”>The International Society for Neurofeedback (ISNR) recently released 3 free (for members) nifty brochures designed to promote public awareness of neurofeedeback. The brochures target professionals and patients alike. Two of the 3 full color brochures highlight the benefits of ISNR membership for professionals, while the third encourages patients to explore neurofeedback as a possible treatment. All brochures discuss the effectiveness of neurofeedback with variety of psychological and developmental disorders. These brochures will also be available for a small fee to non-members. Check the end of this review for full size samples of each brochure.

Continue Reading 0

ISNR Research Foundation Calls For QEEG and Neurofeedback Research Grant Proposals

By Christopher Fisher, PhD on June 22, 2009 in Neurofeedback

The ISNR (International Society for Neurofeedback and Research) Research Foundation seeks to fund large scale, high quality quantitative electroencephalography (QEEG) and neurofeedback studies. They encourage researchers to immediately submit grant proposals for ADHD, Epilepsy, Autistic, and mild to moderate traumatic brain injury (TBI) populations. The ISNR Research Foundation further released a one page document with [...]

Continue Reading 0

DC-EEG in Psychophysiology Applications – A Technical and Clinical Overview

By Marc Saab, MEng on June 1, 2009 in Highly Accessed, Neurofeedback

There has been increasing interest of late in very slow electroencephalographic (EEG) activity. While this sort of activity has been recorded and studied for many years, and used in biofeedback protocols in several applications, it is only recently gaining popularity as another tool with potential mainstream application to clinical neurofeedback. Whatever the tool, before embarking on a new clinical path, a general understanding of the existing research, as well as the technical and neuro-physiological basics is crucial to a successful experience. While there is no need to get overly carried away by the technical issues, a little knowledge can help avoid misunderstandings and common pitfalls, while hopefully leading to better clinical outcomes.

Continue Reading 0

Potential QEEG Markers of Obsessive-Compulsive Disorder (OCD) and Their Implications for Neurofeedback

By Christopher Fisher, PhD on May 16, 2009 in Neurofeedback, QEEG

Using QEEG technology, researchers have identified a left frontotemporal dysfunction in persons who suffer from Obsessive-Compulsive Disorder, better known as OCD*. Persons with OCD have disturbing recurrent thoughts, as well as compulsive behaviors that are difficult to suppress and provide temporary relief from anxiety. The authors note that previous research has generally suggested a frontal [...]

Continue Reading 0

Potential QEEG Markers of Childhood Stuttering And Their Implications for Neurofeedback

By Christopher Fisher, PhD on May 16, 2009 in Disease | Disorders, Neurofeedback, QEEG

Researchers compared the quantitative EEGs (QEEG) of 26 children with a history of stuttering to 21 age matched controls with no stuttering and may have identified important “EEG markers” of pediatric stuttering*. The authors’ epidemiological review of pediatric stuttering finds that this disorder afflicts approximately 1% of prepubertal children typically between 2 to 7 years of age with an peak onset around 3 to 4 years old with boys being 3 times more susceptible to this disorder.

Continue Reading 2
Rejected!

Blue Cross Blue Shield Continues To Block Coverage for Biofeedback and Neurofeedback

By Christopher Fisher, PhD on May 14, 2009 in Healthcare, Neurofeedback

I obtained a copy of a recent Position Statement from Blue Cross/Blue Shield that pertains to biofeedback and neurofeedback from a professional online neurofeedback user group. Unfortunately, Blue Cross/Blue Shield still considers neurofeedback “Investigational and Not Medically Necessary” for all conditions. It appears that Blue Cross/Blue Shield failed to include vital studies, some reviewed on this website, such as Gevensleben et al.’s (2009) ADHD research, Kouijzer et al.’s (2009) Autism research, and Hoedlmoser et al.’s (2008) sleep and memory research. A copy of the entire Position Statement is posted in this report.

Continue Reading 0

The National Institute On Drug Abuse Includes Neurofeedback in Their 5-Year Strategic Plan

By Christopher Fisher, PhD on April 27, 2009 in Neurofeedback

The National Institute on Drug Abuse (NIDA) released their “5 Year Strategic Plan for 2009,” which calls for additional research for “The Exciting Potential of Neurofeedback” (pg. 33). A large national organization’s public recognition of the potential benefits of neurofeedback for substance abuse represents an important development for the field of neurofeedback and is a [...]

Continue Reading 0

Powered by WordPress. Designed by Woo Themes